ADVERTISEMENT

Obstructive sleep apnea: combined noradrenergic antimuscarinic agents are efficacious, says meta-analysis

Miriam Davis, PhD   |   Clinical Summary   |   19 July 2022
ADVERTISEMENT

Takeaway

  • Combined noradrenergic antimuscarinic agents are efficacious for treating obstructive sleep apnea (OSA), according to a meta-analysis.

Why this matters

  • There is currently no pharmacotherapy in routine use for OSA.
  • The success of this therapy supports the rationale that key contributors to OSA are endogenous norepinephrine withdrawal, especially during nonrapid...

          

Topic Challenges

left
right